Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Trelagliptin (Zafatek(®)) was approved in Japan for the treatment of type 2 diabetes mellitus (T2DM)
Chemical Name: (19S)-8-[(dimethylamino)methyl]-19-ethyl-7
Horváth B
[Epub ahead of print] PubMed PMID: 21667043
14)15)4-6-2-1-3-8-5-6/h1-3
(±)-Huperzine A Size:Solid 10 mg Trelagliptin (Zafatek(®)) was approved in() Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD). IC50 value: Target: AChE() Huperzine A exhibited protective effects against d gal induced hepatotoxicity and inflamm aging by inhibiting AChE activity and via the activation of the cholinergic anti inflammatory
US$ 179.00
US$ 99.95
US$ 24.00
US$ 14.99
US$ 109.00
US$ 32.00
US$ 24.00
US$ 14.99
US$ 49.90